BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10851263)

  • 1. Molecular genetic alterations and viral presence in ophthalmic pterygium.
    Detorakis ET; Drakonaki EE; Spandidos DA
    Int J Mol Med; 2000 Jul; 6(1):35-41. PubMed ID: 10851263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of herpes simplex virus and human papilloma virus in ophthalmic pterygium.
    Detorakis ET; Sourvinos G; Spandidos DA
    Cornea; 2001 Mar; 20(2):164-7. PubMed ID: 11248821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus and pterygium in Taiwan.
    Chen YF; Hsiao CH; Ngan KW; Yeung L; Tan HY; Yang KH; Huang SC; Lin KK
    Cornea; 2008 Apr; 27(3):311-3. PubMed ID: 18362659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity and p53 expression in Pterygium.
    Reisman D; McFadden JW; Lu G
    Cancer Lett; 2004 Mar; 206(1):77-83. PubMed ID: 15019163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
    Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine.
    Perra MT; Maxia C; Corbu A; Minerba L; Demurtas P; Colombari R; Murtas D; Bravo S; Piras F; Sirigu P
    Mol Vis; 2006 Sep; 12():1136-42. PubMed ID: 17093398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of loss of heterozygosity and microsatellite instability in human pterygium: clinical correlations.
    Detorakis ET; Sourvinos G; Tsamparlakis J; Spandidos DA
    Br J Ophthalmol; 1998 Nov; 82(11):1324-8. PubMed ID: 9924343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives (Review).
    Detorakis ET; Spandidos DA
    Int J Mol Med; 2009 Apr; 23(4):439-47. PubMed ID: 19288018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV induced cervical carcinogenesis: molecular basis and vaccine development.
    Kaufmann AM; Backsch C; Schneider A; Dürst M
    Zentralbl Gynakol; 2002 Nov; 124(11):511-24. PubMed ID: 12796844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of p53 tumor suppressor gene in pterygia.
    Weinstein O; Rosenthal G; Zirkin H; Monos T; Lifshitz T; Argov S
    Eye (Lond); 2002 Sep; 16(5):619-21. PubMed ID: 12194078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia.
    Di Girolamo N
    Eye (Lond); 2012 Feb; 26(2):202-11. PubMed ID: 22134594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite instability and loss of heterozygosity in human pterygia.
    Spandidos DA; Sourvinos G; Kiaris H; Tsamparlakis J
    Br J Ophthalmol; 1997 Jun; 81(6):493-6. PubMed ID: 9274415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral involvement in the pathogenesis and clinical features of ophthalmic pterygium (Review).
    Chalkia AK; Spandidos DA; Detorakis ET
    Int J Mol Med; 2013 Sep; 32(3):539-43. PubMed ID: 23856952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia.
    Detorakis ET; Zafiropoulos A; Arvanitis DA; Spandidos DA
    Eye (Lond); 2005 Feb; 19(2):210-4. PubMed ID: 15232598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma.
    Obermann EC; Diss TC; Hamoudi RA; Munson P; Wilkins BS; Camozzi ML; Isaacson PG; Du MQ; Dogan A
    J Pathol; 2004 Feb; 202(2):252-62. PubMed ID: 14743509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
    Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.
    Coukos G; Makrigiannakis A; Kang EH; Rubin SC; Albelda SM; Molnar-Kimber KL
    Clin Cancer Res; 2000 Aug; 6(8):3342-53. PubMed ID: 10955822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presences of human papillomavirus DNA (HPV) and immunohistochemical p53 overexpression in papillomas of oral cavity.
    Barzał-Nowosielska M; Miasko A; Chyczewski L
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():105-7. PubMed ID: 15638389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 Gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma.
    Fujiki T; Haraoka S; Yoshioka S; Ohshima K; Iwashita A; Kikuchi M
    Int J Oncol; 2002 Apr; 20(4):669-79. PubMed ID: 11894109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.